Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
12/22/2004 | EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
12/22/2004 | EP1487437A1 Methods of treatment with selective ep4 receptor agonists |
12/22/2004 | EP1487435A1 Azetidine derivatives as ccr-3 receptor antagonists |
12/22/2004 | EP1436266A4 Methods and compositions of novel triazine compounds |
12/22/2004 | EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
12/22/2004 | CN1556803A New organic compounds for electroluminescence and oganic electroluminescent devices using the same |
12/22/2004 | CN1556788A Muscarinic agonists |
12/22/2004 | CN1556702A Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
12/22/2004 | CN1181059C Quinoline-4-base derivative I |
12/21/2004 | US6833456 Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use |
12/21/2004 | US6833387 Chemical compounds |
12/21/2004 | US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders. |
12/21/2004 | CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
12/16/2004 | WO2004108718A1 Aroyl semicarbazide derivatives against thromboembolic diseases |
12/16/2004 | WO2004108717A1 Sulptionamide compounds that modulate chemokine receptor activity (ccr4) |
12/16/2004 | WO2004108716A1 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
12/16/2004 | WO2004108715A1 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity |
12/16/2004 | WO2004108714A1 Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
12/16/2004 | WO2004108713A1 Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents |
12/16/2004 | WO2004108712A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
12/16/2004 | WO2004108690A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
12/16/2004 | WO2004108683A1 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
12/16/2004 | WO2004108672A1 Isoindolin-1-one compounds as kinase inhibitors |
12/16/2004 | WO2004108133A2 Modulators of vr1 receptor |
12/16/2004 | WO2004108085A2 Methods for the protection of memory and cognition |
12/16/2004 | WO2004087686A3 Benzopyran compounds useful for treating inflammatory conditions |
12/16/2004 | WO2004080411A3 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
12/16/2004 | WO2004037789A8 Methylene urea derivatives as raf-kinase inhibitors |
12/16/2004 | WO2003063797A8 Cycloalkyl inhibitors of potassium channel function |
12/16/2004 | US20040254376 Cyclic amidine derivative |
12/16/2004 | US20040254374 Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases |
12/16/2004 | US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects |
12/16/2004 | US20040254183 Pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections |
12/16/2004 | US20040254177 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
12/16/2004 | US20040254159 Antiproliferative agents |
12/16/2004 | US20040254158 1,1-Disubstituted cycloalkyl derivatives as factor Xa inhibitors |
12/16/2004 | CA2528925A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
12/16/2004 | CA2528233A1 Aroylsemicarbazide derivatives against thromboembolic diseases |
12/16/2004 | CA2527814A1 Isoindolin-1-one compounds as kinase inhibitors |
12/16/2004 | CA2527793A1 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
12/16/2004 | CA2527576A1 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity |
12/16/2004 | CA2527573A1 Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents |
12/16/2004 | CA2527341A1 Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
12/16/2004 | CA2527114A1 Methods for the protection of memory and cognition |
12/15/2004 | EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
12/15/2004 | EP1485387A1 Carbamates as hiv protease inhibitors |
12/15/2004 | EP1485377A1 Pyranones useful as atm inhibitors |
12/15/2004 | EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase |
12/15/2004 | EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
12/15/2004 | EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
12/15/2004 | EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS |
12/15/2004 | EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
12/15/2004 | EP1485353A1 New inhibitors of histone deacetylase |
12/15/2004 | EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
12/15/2004 | EP1485115A2 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers |
12/15/2004 | EP1485101A1 Non-sedating barbituric acid derivatives |
12/15/2004 | EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases |
12/15/2004 | EP1485099A1 Inhibitors of histone deacetylase |
12/15/2004 | EP1485093A1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
12/15/2004 | EP1485089A1 Combination treatments for chemokine-mediated diseases |
12/15/2004 | EP1484971A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
12/15/2004 | EP1337520B1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers |
12/15/2004 | EP1278742B1 Chromenylmethylpyrimidinediamines as antibacterial agents |
12/15/2004 | EP1091957B1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria |
12/15/2004 | EP0863755B1 Antithrombotic diamines |
12/15/2004 | CN1555373A Insecticidal 3-(2,6-disubstituted phenyl)-5-[4- or 5-arylthien-2- or -3-yl]-1,2,4-triazoles |
12/15/2004 | CN1555262A Novel 4,5-dihydro-1H-pyrazole derivatives having CB*-antagonistic activity |
12/15/2004 | CN1555260A Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
12/15/2004 | CN1554654A Synthetic method for thiagabine and its raceme and S-configuration and its method for preparing amorphous powder |
12/15/2004 | CN1180050C Metal ligand compound, luminous device and display device |
12/15/2004 | CN1179961C Sulfonamides for treatment of endothelin-mediated disorders |
12/15/2004 | CN1179948C HIV protease inhibitors |
12/15/2004 | CN1179945C Indole derivatives, process for preparation of same and use thereof |
12/15/2004 | CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
12/14/2004 | US6831178 Crystal structure; stability; bioavailability |
12/14/2004 | US6831175 Such as N,N-dimethyl-N-(2-((5-((E)-2-pyridin-4-ylvinyl) pyridin-3-yl)oxy)ethyl)amine |
12/14/2004 | US6831096 Effective against both A and B forms of influenza; oral bioavailability |
12/14/2004 | US6831094 For therapy of central nervous system disorders such as anxiety, depression, motor disorders |
12/14/2004 | US6831093 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
12/14/2004 | US6831075 Heterocyclic substituted pyrazolones |
12/09/2004 | WO2004106329A2 Novel antiinfective compounds and their pharmaceutical compositions |
12/09/2004 | WO2004106328A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
12/09/2004 | WO2004106321A1 4-aryl-5h-thiophene-2-one derivatives and its preparation and use |
12/09/2004 | WO2004106307A2 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
12/09/2004 | WO2004106302A1 Novel substituted 3-sulfur indoles |
12/09/2004 | WO2004106295A2 Substituted piperodines and pyrrolidines as calcium sensing receptor modulators and method |
12/09/2004 | WO2004105752A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors |
12/09/2004 | WO2004105488A1 Hydrazone derivatives for combatting harmful insects and arachnids |
12/09/2004 | WO2004094388A3 Indazole derivatives as jnk inhibitors |
12/09/2004 | WO2004089892A3 Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity |
12/09/2004 | WO2003080582A3 Fredericamycin derivatives |
12/09/2004 | US20040249155 1-(omego-substituted-2-[(hetero)arylcarbonylamino]alkanoyl)-4-(1-methylpiperidin-4-yl)piperidine derivatives; e.g., 1-[N-(Indole-6-carbonyl)-D-serinyl]-4-(1-methylpiperidin-4-yl)piperidine Hydrochloride |
12/09/2004 | US20040248954 carbocyclic sulfides such as 3-cyclohexylsulfanyl-5-methoxy-6-methyl-benzo[b]thiophene-2-carboxylic acid (1H-tetrazol-5-yl)-amide, used as phosphatidyl inositol 3-kinase inhibitors; antiinflammatory and anticarcinogenic agents; prophylaxis of cardiovascular disorders |
12/09/2004 | US20040248953 3-Arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
12/09/2004 | US20040248944 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
12/09/2004 | US20040248938 Substituted piperidines |
12/09/2004 | US20040248932 Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence |
12/09/2004 | US20040248923 Novel 4-anilinoquinoline-3-carboxamides |
12/09/2004 | US20040248890 Voltage gated sodium and calcium channel inhibitors |
12/09/2004 | US20040248886 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide |